TIMP1 and colorectal cancer: These results were supported by data from cellular models showing that exposure of colorectal cancer (CRC) cells to exogenously added recombinant TIMP‐1 promoted a more aggressive behavior in these cells, specifically in KRAS‐mutated cells (Tarpgaard et al., 2016).